MedPath

Rolling it out: Intervention to improve driving cessation outcomes for people with dementia and their families across metropolitan and regional areas

Not Applicable
Completed
Conditions
dementia
community mobility / lifespace
social isolation
wellbeing
Neurological - Dementias
Registration Number
ACTRN12618000388213
Lead Sponsor
Dr Theresa Scott
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
44
Inclusion Criteria

(1) the person with dementia will be eligible to participate if he/she has mild to moderate dementia (Mini-Mental State Examination score 12-26 (inclusive), or clinical diagnosis), is living in the community, has ceased driving or plans to cease driving in the next six months and driving cessation is an issue for him/her, and is able to provide informed consent for participation (or have a guardian able to do so) and has a family member/carer able to participate in the trial; (2) family members will be eligible to participate if they identify as the main person providing ongoing informal care of the person with dementia

Exclusion Criteria

Persons with dementia may be excluded from participation if they have never obtained a drivers' license or have ceased driving some years ago (2 or more years), have a major physical illness or sensory impairment (or reason other than dementia) that resulted in their stopping driving; or insufficient command of English to be able to respond to study questionnaires.
Family members or support persons may be excluded if they are younger than 18 years of age, or they do not have informal care of the person with dementia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ifespace / Community mobility collected via a study provided Smartphone using passive collection of GPS data. GPS data will be collected for a seven day period at each of three timepoints. In addition lifespace is measured with the Lifespace Questionnaire (Stalvey, Owsley, Sloane, & Ball, K. 1999) at each of three timepoints. These measures will be augmented with collecting the 'number of episodes away from home during the past week' at each of three time points. [T1 = Baseline, prior to commencement<br>T2 = First follow-up, at week 8<br>T3 = Second Follow-up, at 3 months post intervention completion <br>]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath